Insmed Incorporated

    Jurisdiction
    United States
    LEI
    529900Q55QAG41CCAC11
    ISIN
    US4576693075 (INSM)
    Sectors
    1. Healthcare
    2. Medical - Pharmaceuticals

    Scores

    InsiderPie Expert Score
    57 / 100
    Better than peer group:
    47 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Read full profile

    Fundamentals

    Net revenue
    €339.56M
    Gross margin
    75.4%
    EBIT
    -€806.77M
    EBIT margin
    -237.6%
    Net income
    -€882.24M
    Net margin
    -259.8%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €903.93M +166.2% -€605.29M -31.4%
    €1.70B +88.5% -€70.60M -88.3%
    €2.76B +61.9% €683.41M -1,068.0%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Flammer Martina M.D. Chief Medical Officer -187K $144.34 -$26.94M
    Smith Michael Alexander Chief Legal Officer -24K $143.89 -$3.49M
    SHAROKY MELVIN MD N/A -10K $129.50 -$1.30M
    Adsett Roger Chief Operating Officer -25K $127.58 -$3.19M
    Lewis William Chair and CEO -6.9K $128.40 -$881.47K

    Congress transactions

    Name Transaction date Value
    Gilbert Cisneros September 12, 2025 $1.00K–$15.00K
    Gilbert Cisneros August 14, 2025 $1.00K–$15.00K
    Josh Gottheimer July 16, 2025 $1.00K–$15.00K
    Josh Gottheimer May 14, 2025 $1.00K–$15.00K
    Josh Gottheimer July 9, 2024 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Stanley Druckenmiller 1.4M $104.45M +776K Buy
    George Soros 307K $23.44M -148K Sell

    Earnings Calls

    Add to watchlist

    Notifications